GLP-2 (TR)

$59.99

Shipping calculated at checkout.

Available in stock (100)

A 39-amino-acid dual agonist peptide targeting the GIP and GLP-1 receptors, studied in dual-receptor metabolic signaling and body composition research. Premium Research Peptide.

Dosage: 30MG

30MG 60MG

Quantity: 1 Bottle

1 Bottle 2 Bottles 3 Bottles

Free International Shipping over $150
Free Returns Within 7 days

Limited time offer

Don’t miss out on this limited-time advantage crafted for you

GLP-2 (TR)

$59.99

Fast Delivery

7 Days Free Returns

Secure Payment

Research with confidence, supported by clear compound information

For Research Use Only

Lyophilized Peptide

Technical Specifications

Published Research References

Compound Information

Technical specifications

MOLECULAR PROFILE

What Is Tirzepatide?

A 39-residue synthetic linear peptide that acts as a dual agonist at both the GIP and GLP-1 receptors. A C20 fatty diacid chain at Lys-20 drives albumin binding for a once-weekly circulation profile.

Dual-Incretin Analog Albumin-Bound

Type Dual GIP/GLP-1 receptor agonist (dual-incretin analog)

CAS Number 2023788-19-2

Molecular Formula C225H348N48O68

Molecular Weight 4813.45 g/mol

Amino Acids 39 (residues)

Modification C20 fatty diacid at Lys-20

View on DrugBank

STORAGE REQUIREMENTS

Stability Information

Follow appropriate laboratory storage practices to help maintain compound stability.

Freeze for storage Refrigerate after reconstitution Protect from light

Lyophilized Powder -20°C long-term storage

Keep the sealed vial frozen until required for laboratory research.

After Reconstitution 2–8°C refrigerated storage

Maintain consistent refrigeration and avoid unnecessary temperature cycling.

Light Protection Away from direct light

Protect the vial from direct light, excessive heat, and moisture.

RESEARCH SOURCES

Peer-reviewed research and verified compound data.

DrugBank DB15171

The DrugBank record for tirzepatide, providing compound identification, classification, pharmacological data, and documented molecular information.

View DrugBank Record

CID 156588324

The PubChem compound record for tirzepatide, providing standardized identifiers, molecular properties, chemical information, and database documentation.

View PubChem Record

Tirzepatide DrugBank DB15171 compound identification and research data

Tirzepatide PubChem CID 156588324 molecular properties and chemical information

Research use only notice stating not for human consumption

Primary restriction Not for human consumption.

Intended Research Use

This product is sold exclusively for laboratory research, analytical testing, and educational purposes. It is not intended for human or veterinary use, consumption, administration, diagnosis, treatment, mitigation, cure, or prevention of disease.

Information Disclaimer

Any clinical trial data, technical information, or research findings presented on this page are provided for educational reference only. They should not be interpreted as medical advice, treatment guidance, or product claims.

Purchaser Responsibility

By purchasing this product, you confirm that you are a qualified researcher and will use it responsibly and in accordance with all applicable laws and regulations.

Discover more in our FAQ

What is GLP-2 (Tirzepatide)?

GLP-2 is a 39-amino-acid synthetic peptide corresponding to tirzepatide. It is studied as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor pathways.

2. What makes GLP-2 different from a single-receptor GLP-1 peptide?

Unlike peptides studied primarily for GLP-1 receptor activity, GLP-2 is designed for research involving both GIP and GLP-1 receptor signaling. This dual-receptor profile supports laboratory investigation of integrated incretin signaling and related metabolic pathways.

3. In what form is this research peptide supplied?

GLP-2 is supplied as a lyophilized, or freeze-dried, peptide powder. Lyophilization supports controlled transportation, storage, and laboratory handling before the material is used in an appropriate research setting.

4. Where can I review additional information about tirzepatide?

Additional compound information is available through the authoritative DrugBank record DB15171 and PubChem compound record CID 156588324. These external resources provide standardized identifiers, molecular properties, classification, and documented compound information.

5. What is this product intended for?

This product is intended strictly for in-vitro laboratory research, analytical testing, and educational research purposes. It is not intended for human or veterinary use, consumption, administration, diagnosis, treatment, or any household application.

Researcher verification